19 Participants Needed

Blood Flow Restriction Therapy for Ruptured Achilles Tendon

HG
Overseen ByHaley Goble
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Methodist Hospital Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Blood Flow Restriction Therapy for ruptured Achilles tendon?

Research shows that Blood Flow Restriction Therapy (BFRT) can help improve muscle strength and mass, which is beneficial for rehabilitation after injuries. It has been effective in strengthening muscles and preventing muscle loss in various conditions, suggesting it could aid recovery in tendon injuries like a ruptured Achilles tendon.12345

Is Blood Flow Restriction Therapy generally safe for humans?

Blood Flow Restriction Therapy (BFRT) is generally considered safe for healthy individuals, but it may cause increased blood pressure and other cardiovascular issues, especially in people with existing health conditions like heart disease or diabetes. It's important to have a medical evaluation before starting BFRT to ensure it's safe for you.15678

How is Blood Flow Restriction Therapy different from other treatments for a ruptured Achilles tendon?

Blood Flow Restriction Therapy (BFRT) is unique because it allows for strength training with low loads by restricting blood flow to the muscles, which can help improve muscle function and strength without the need for heavy weights. This makes it particularly useful for early rehabilitation stages, potentially leading to faster recovery compared to traditional methods that require higher intensity exercises.13456

What is the purpose of this trial?

The purpose of this study is to determine if blood flow restriction therapy after Achilles tendon rupture reconstruction decreases post-operative calf atrophy, improves reported outcomes, and ultimately decreases return to play time.

Eligibility Criteria

This trial is for individuals who have recently undergone surgery to repair a ruptured Achilles tendon. Specific eligibility criteria are not provided, but typically participants would need to be in stable health post-surgery and able to commit to the rehabilitation program.

Inclusion Criteria

I am undergoing or scheduled for PARS or open repair surgery.
Proposed PT with Methodist Location
I am 18 years old or older.
See 1 more

Exclusion Criteria

Pregnant
I have heart, kidney, liver, or lung disease.
I have diabetes.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-operative Assessment

Participants complete full body composition scans (DEXA) and questionnaires before surgery

1 week
1 visit (in-person)

Post-operative Treatment

Participants undergo either BFR therapy in addition to standard PT or standard PT alone

16 weeks
Twice a week (in-person)

Follow-up

Participants are monitored for muscle mass preservation, bone density, range of motion, and patient-reported outcomes

16 weeks
4 visits (in-person)

Treatment Details

Interventions

  • Blood flow restriction with Delfi PTS
Trial Overview The study is testing whether using blood flow restriction therapy alongside physical therapy after an Achilles tendon rupture surgery can reduce muscle loss, improve patient outcomes, and shorten the time it takes for athletes to return to their sport.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Standard of Care (control) groupExperimental Treatment1 Intervention
The control group will undergo the normal Achilles tendon rupture reconstruction rehab protocol as determined by Drs. Varner and McCulloch.
Group II: Blood flow restriction groupExperimental Treatment2 Interventions
The study group will undergo normal Achilles tendon rupture reconstruction rehab modified by use of a tourniquet for blood flow restriction during selected exercises.

Blood flow restriction with Delfi PTS is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Blood Flow Restriction Therapy for:
  • Post-surgical rehabilitation
  • Musculoskeletal injuries
  • Sports injuries
  • Joint pain
  • Tendinopathies
  • Fractures
  • Osteoporosis
🇪🇺
Approved in European Union as Blood Flow Restriction Therapy for:
  • Rehabilitation after Achilles tendon rupture
  • Muscle strengthening
  • Pain relief
  • Pre-surgical strengthening
  • Post-surgical rehabilitation

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Methodist Hospital Research Institute

Lead Sponsor

Trials
299
Recruited
82,500+

Findings from Research

In a controlled study involving 40 rats, ischemic therapies like blood flow restriction therapy (BFRT) and repetitive restriction of muscle blood flow (RRMBF) did not lead to improvements in muscle mass, strength, or satellite cell density, suggesting limited efficacy for these methods in enhancing muscle function.
However, the RRMBF group showed significantly elevated growth hormone (GH) levels, indicating a potential biochemical response to this type of ischemic therapy, even though it did not translate to physical improvements in muscle characteristics.
Local and Systemic Effects of Blood Flow Restriction Therapy in an Animal Model.Ramme, AJ., Darcy, R., Rourke, BJ., et al.[2020]
Blood flow restriction training (BFRT) was safely applied to two female athletes with shoulder pain, resulting in significant improvements in shoulder function, range of motion, and muscle strength after 16 to 22 treatment sessions.
The study suggests that BFRT could be an effective addition to traditional rehabilitation methods for managing subacromial pain, although further research is needed to confirm these findings.
Blood Flow Restriction Training for Subacromial Pain: Two Case Reports.Miller, M., Zeppieri, G., Farmer, KW., et al.[2023]
Blood Flow Restriction Training (BFRT) is an effective and innovative rehabilitation technique that can prevent muscle atrophy in post-surgical patients during initial bed rest, improving muscle function, strength, and mass.
BFRT, when combined with aerobic activities, not only enhances muscle strength but also improves cardiovascular fitness, making it a versatile treatment option for various conditions related to muscle weakness and degeneration.
Blood Flow Restriction Training-An Overview and Implication in New Generation Physical Therapy: A Narrative Review.Saraf, A., Goyal, M., Goyal, K.[2022]

References

Local and Systemic Effects of Blood Flow Restriction Therapy in an Animal Model. [2020]
Blood Flow Restriction Training for Subacromial Pain: Two Case Reports. [2023]
Blood Flow Restriction Training-An Overview and Implication in New Generation Physical Therapy: A Narrative Review. [2022]
Blood Flow Restriction Resistance Training in Tendon Rehabilitation: A Scoping Review on Intervention Parameters, Physiological Effects, and Outcomes. [2022]
The Safety of Blood Flow Restriction Training as a Therapeutic Intervention for Patients With Musculoskeletal Disorders: A Systematic Review. [2020]
Blood Flow Restriction Therapy: From Development to Applications. [2020]
Blood flow restriction therapy with exercise are no better than exercise alone in improving athletic performance, muscle strength, and hypertrophy: a systematic review and meta-analysis. [2023]
A Useful Blood Flow Restriction Training Risk Stratification for Exercise and Rehabilitation. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security